Fig. 1 · Structure
Documents & Downloads
(+)-Tyrphostin B44
EGRF Inhibitor
(+)-Tyrphostin B44 is an Epidermal Growth Factor Receptor (EGFR) inhibitor known for its antitumor properties. This compound exhibits significant biological activity in inhibiting EGFR signaling pathways, which are critical in cellular proliferation and survival. It has applications in cancer research, particularly in studying the effects of EGFR inhibition on tumor growth and progression.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 133550-37-5 |
| Applications | EGRF Inhibitor |
| Formula | C18H16N2O3 |
| Molecular Weight | 308.33 |
| Synonyms | Tyrphostin AG 835; Tyrphostin B 50 |
| SMILES | O=C(N[C@H](C1=CC=CC=C1)C)/C(C#N)=C/C2=CC=C(O)C(O)=C2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.